Publication | Closed Access

A Six-week Dose-response Study of the Ocular Hypotensive Effect of Dorzolamide With a One-year Extension

Six-week Dose-response StudyOcular DiseaseOphthalmologyOne-year ExtensionMedicineEye HealthPharmacotherapyGlaucomaOcular PharmacologyPharmacologyOcular Hypotensive Effect